Fig. 1From: Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancerKaplan-Meier survival estimates between EBRT and SBRT for unfavorable intermediate (a) and high (b) risk prostate cancerBack to article page